Sociodemographic and clinical characteristics of suspected difficult-to-treat depression
This study sheds light on the intricate nature of suspected DTD, emphasizing the coexistence of MDD, BD, and subthreshold depression within this category. Our findings underscore the necessity for thorough evaluations and tailored treatment approaches for managing suspected DTD.
Authors
- Koichiro Watanabe (ORCID: https://orcid.org/0000-0002-0736-7070)
- Takashi Tsuboi (ORCID: https://orcid.org/0000-0002-8253-8888)
- Izumi Nagashima
- Hitoshi Sakurai (ORCID: https://orcid.org/0000-0002-5399-7946)
- Yuki Oe (ORCID: https://orcid.org/0000-0002-4947-5395)
- Mariko Kurihara
- Yasuyuki Matsumoto (ORCID: https://orcid.org/0000-0003-2606-2616)
- Masami Murao
- Tomonari Hayasaka (ORCID: https://orcid.org/0000-0002-5555-0902)
Institutions
- Kyorin University (JP)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fpsyt.2024.1371242
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Pfizer
- Mylan
- Eisai
- Meiji Seika Pharma
- Shionogi
- Otsuka Pharmaceutical
- Teijin Pharma
- Mitsubishi Tanabe Pharma Corporation
- H. Lundbeck A/S
- Japan Society for the Promotion of Science
- Daiichi Sankyo Europe